Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Incyte Genomics Posts Shrunken Q1 Revenue, Widened Loss

NEW YORK, May. 1 - Incyte Genomics today posted a wider first-quarter loss and blamed falling subscription and licensing revenue.

Revenue fell to $29 million from $51 million after the firm discontinued its custom genomic product lines last October, the company said.


R&D spending in the quarter ended March 31 fell to $33.6 million from almost $53 million one year ago, though net loss managed to inch higher to $13.4 million, or $.20 per diluted share, compared to $10.3 million, or $.16 a share, year over year.


Incyte said it had just under $100 million in cash and cash equivalents as of March 31.


Click here for more information.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.